Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis?

Coyle TE, Bair AK, Stein C, Vajpayee N, Mehdi S, Wright J.

Am J Hematol. 2005 Apr;78(4):256-60.

PMID:
15795916
[PubMed - indexed for MEDLINE]
2.

Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.

Liu S, Klisovic RB, Vukosavljevic T, Yu J, Paschka P, Huynh L, Pang J, Neviani P, Liu Z, Blum W, Chan KK, Perrotti D, Marcucci G.

J Pharmacol Exp Ther. 2007 Jun;321(3):953-60. Epub 2007 Mar 26.

PMID:
17389244
[PubMed - indexed for MEDLINE]
Free Article
3.

Translocation-positive acute myeloid leukemia associated with valproic acid therapy.

Williams DC Jr, Massey GV, Russell EC, Riley RS, Ben-Ezra J.

Pediatr Blood Cancer. 2008 Mar;50(3):641-3.

PMID:
17262798
[PubMed - indexed for MEDLINE]
4.

Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.

Lin CM, Thajeb P.

Metab Brain Dis. 2007 Mar;22(1):105-9. Epub 2007 Jan 17. Erratum in: Metab Brain Dis. 2007 Dec;22(3-4):425.

PMID:
17226098
[PubMed - indexed for MEDLINE]
5.

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.

Kuendgen A, Knipp S, Fox F, Strupp C, Hildebrandt B, Steidl C, Germing U, Haas R, Gattermann N.

Ann Hematol. 2005 Dec;84 Suppl 1:61-6.

PMID:
16270213
[PubMed - indexed for MEDLINE]
6.

Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera.

Sasaki K, Yamagata T, Mitani K.

Cancer Sci. 2008 Feb;99(2):414-22. doi: 10.1111/j.1349-7006.2007.00699.x.

PMID:
18271940
[PubMed - indexed for MEDLINE]
7.

Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments.

Harikrishnan KN, Karagiannis TC, Chow MZ, El-Osta A.

Cell Cycle. 2008 Feb 15;7(4):468-76. Epub 2007 Dec 4.

PMID:
18239454
[PubMed - indexed for MEDLINE]
Free Article
8.

Acute seizures due to a probable interaction between valproic acid and meropenem.

Coves-Orts FJ, Borrás-Blasco J, Navarro-Ruiz A, Murcia-López A, Palacios-Ortega F.

Ann Pharmacother. 2005 Mar;39(3):533-7. Epub 2005 Feb 8.

PMID:
15701769
[PubMed - indexed for MEDLINE]
9.

Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.

Allan RW.

Hematology. 2007 Dec;12(6):493-6. Review.

PMID:
17852444
[PubMed - indexed for MEDLINE]
10.

The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia.

Kuendgen A, Schmid M, Schlenk R, Knipp S, Hildebrandt B, Steidl C, Germing U, Haas R, Dohner H, Gattermann N.

Cancer. 2006 Jan 1;106(1):112-9.

PMID:
16323176
[PubMed - indexed for MEDLINE]
Free Article
11.

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.

Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, Romanski A, Kramer OH, Kampfmann M, Hoelzer D, Neubauer A, Ruthardt M, Ottmann OG.

Cancer. 2005 Dec 15;104(12):2717-25.

PMID:
16294345
[PubMed - indexed for MEDLINE]
Free Article
12.

Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.

Navarro JT, Feliu E, Grau J, Espinet B, Colomer D, Ribera JM, Oriol A, Granada I, Juncà J, Millá F.

Am J Hematol. 2007 Sep;82(9):849-51.

PMID:
17563075
[PubMed - indexed for MEDLINE]
13.

Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.

Quijano S, López A, Rasillo A, Sayagués JM, Barrena S, Sánchez ML, Teodosio C, Giraldo P, Giralt M, Pérez MC, Romero M, Perdiguer L, Orfao A.

Cytometry B Clin Cytom. 2008 May;74(3):139-49.

PMID:
18061951
[PubMed - indexed for MEDLINE]
Free Article
14.

Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome.

Soriano AO, Yang H, Faderl S, Estrov Z, Giles F, Ravandi F, Cortes J, Wierda WG, Ouzounian S, Quezada A, Pierce S, Estey EH, Issa JP, Kantarjian HM, Garcia-Manero G.

Blood. 2007 Oct 1;110(7):2302-8. Epub 2007 Jun 27.

PMID:
17596541
[PubMed - indexed for MEDLINE]
Free Article
15.

Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.

Mahlknecht U, Schönbein C.

Haematologica. 2008 Mar;93(3):443-6. doi: 10.3324/haematol.11796. Epub 2008 Feb 11.

PMID:
18268283
[PubMed - indexed for MEDLINE]
Free Article
16.

[A case of acute pancreatitis during administration of valproic acid].

Momota T, Ito S, Kobayashi K, Mimasu S, Kuniya T.

No To Hattatsu. 1993 Sep;25(5):453-8. Review. Japanese.

PMID:
8398236
[PubMed - indexed for MEDLINE]
17.

Acute pancreatitis in children from Valproic acid: case series and review.

Grauso-Eby NL, Goldfarb O, Feldman-Winter LB, McAbee GN.

Pediatr Neurol. 2003 Feb;28(2):145-8. Review.

PMID:
12699868
[PubMed - indexed for MEDLINE]
18.

Pancreatitis, complicated by a pancreatic pseudocyst associated with the use of valproic acid.

Houben ML, Wilting I, Stroink H, van Dijken PJ.

Eur J Paediatr Neurol. 2005;9(2):77-80. Review.

PMID:
15843073
[PubMed - indexed for MEDLINE]
19.

On the toxicity of valproic-acid.

Moreiras Plaza M, Rodríguez Goyanes G, Cuiña L, Alonso R.

Clin Nephrol. 1999 Mar;51(3):187-9.

PMID:
10099893
[PubMed - indexed for MEDLINE]
20.

Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.

Toubai T, Tanaka J, Higa T, Ota S, Ibata M, Shono Y, Mashiko S, Miura Y, Umehara S, Kahata K, Toyoshima N, Morioka M, Asaka M, Kasai M, Imamura M.

Am J Hematol. 2005 Jan;78(1):67-70.

PMID:
15609290
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk